Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium

Journal of Oral Pathology and Medicine

Volumn 33, Issue 2, 2004, Pages 87-95

  Ikarashi, Terué ^a   Ida Yonemochi, Hiroko ^a   Ohshiro, Kazufumi ^a   Cheng, Jun ^a   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Basement membrane type heparan sulfate proteoglycan; Epithelial dysplasia; Oral mucosa; Perlecan; Squamous cell carcinoma

Indexed keywords

HEPARAN SULFATE; PERLECAN; PERLECAN CORE PROTEIN; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

AMELOBLASTOMA; ARTICLE; BASAL CELL; BASEMENT MEMBRANE; CELL ADHESION; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DYSPLASIA; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR SPACE; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETICULUM CELL; SQUAMOUS CELL CARCINOMA; STELLATE CELL; STROMA;

CARCINOMA, SQUAMOUS CELL; EPITHELIAL CELLS; EPITHELIUM; EXTRACELLULAR SPACE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUTH MUCOSA; MOUTH NEOPLASMS;

EID: 0842348931     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00026.x     Document Type: Article

References (41)

1. Iozzo RV, Cohen IR, Grassel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 1994; 302: 625-39.
2. Murdoch AD, Liu B, Schwarting R, Tuan RS, Lozzo RV. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissue as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 1994; 42: 239-49.
3. Saku T, Cheng J, Okabe H, Koyama Z. Immunolocalization of basement membrane molecules in the stroma of salivary gland pleomorphic adenoma. J Oral Pathol Med 1990; 19: 208-14.
4. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer 1992; 69: 2631-40.
5. Murata M, Hara K, Saku T. Dynamic distribution of basic fibroblast growth factor during epulis formation: an immunohistochemical study in an enhanced healing process of the gingiva. J Oral Pathol Med 1997; 26: 224-32.
6. Okuda K, Murata M, Sugimoto M, et al. TGF-β1 influences early gingival wound healing in rats: an immunohistochemical evaluation of stromal remodelling by extracellular matrix molecules and PCNA. J Oral Pathol Med 1998; 27: 463-9.
7. Yonemochi H, Noda T, Saku T. Pericoronal hamartomatous lesions in the opercula of teeth delayed in eruption: an immunohistochemical study of the extracellular matrix. J Oral Pathol Med 1998; 27: 441-52.
8. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Laboratory Invest 1993; 68: 520-7.
9. Sabit H, Tsuneyama K, Shimonishi T, et al. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Pathol Int 2001; 51: 248-56.
10. Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch 2000; 437: 122-8.
11. Ida-Yonemochi H, Ikarashi T, Nagata M, Hoshina H, Takagi R, Saku T. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch 2002; 441: 165-73.
12. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological Typing of Cancer and Precancerous of the Oral Mucosa, World Health Organization International Histological Classification of Tumors. Berlin: Springer-Verlag, 1997; pp. 25-6.
13. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 519-39.
14. Saku T, Furthmayr H. Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J Biol Chem 1989; 264: 3514-23.
15. Mikami S, Ohashi K, Usui Y, et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001; 92: 1062-73.
16. Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002; 21: 3919-26.
17. Rauschmayr T, Groves RW, Kupper TS. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci USA 1997; 94: 5814-9.
18. Fujiwara Y, Higuchi K, Takashima T, et al. Increased expression of epidermal growth factor receptors in basal cell hyperplasia of the oesophagus after acid reflux oesophagitis in rats. Aliment Pharmacol Ther 2002; 16: 52-8.
19. Takenaka H, Yasuno H, Kishimoto S. Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. Arch Dermatol Res 2002; 294: 331-8.
20. Saku T, Okabe H. Differential lectin-bindings in normal and precancerous epithelium and squamous cell carcinoma of the oral mucosa. J Oral Pathol Med 1989; 18: 438-45.
21. Saku T, Shibata Y, Koyama Z, Cheng J, Okabe H, Yeh Y. Lectin histochemistry of cystic jaw lesions: an aid for differential diagnosis between cystic ameloblastoma and odontogenic cysts. J Oral Pathol Med 1991; 20: 108-13.
22. Dunlevy JR, Hassell JR. Heparan sulfate proteoglycan in basement membranes. Perlecan, Agrin, and Collagen XVII. In: Iozzo RV, ed. Proteoglycans Structure, Biology, and Molecular Interactions. New York: Marcel Dekker, Inc, 2000: 275-307.
23. Saika S, Kawashima Y, Okada Y, et al. Immunohistochemical and ultrastructural analysis of dysplastic epithelium of human ocular surface: basement membrane and intermediate filament. Cornea 1999; 18: 343-52.
24. White FH, Gohari K. Alterations in the volume of the intercellular space between epithelial cells of the hamster cheek-pouch: quantitative studies of normal and carcinogen-treated tissues. J Oral Pathol 1984; 13: 244-54.
25. Kocher O, Amaudruz M, Schindler AM, Gabbiani G. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study. J Submicrosc Cytol 1981; 13: 267-81.
26. Ida-Yonemochi H. Basement membrane type heparan sulfate proteoglycan in mouse tooth germs. Jpn J Oral Biol 2002; 44: 416.
27. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79: 1005-13.
28. Mongiat M, Taylor K, Otto J, et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem 2000; 275: 7095-100.
29. Dodge GR, Boesler EW, Jimenez SA. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells. Laboratory Invest 1995; 73: 649-57.
30. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 573-9.
31. Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP. Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 1994; 168: 381-5.
32. Walton LJ, Macey MG, Thornhill MH, Farthing PM. Intraepithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med 1998; 27: 116-23.
33. Clark RA, Alon R, Springer TA. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 1996; 134: 1075-87.
34. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992; 119: 961-75.
35. Friedmann Y, Vlodavsky I, Aingom H, et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 2000; 157: 1167-75.
36. Vlodavsky I, Eldor A, Bar-Ner M, Fridman R, Cohen IR, Klagsbrun M. Heparan sulfate degradation in tumor cell invasion and angiogenesis. Adv Exp Med Biol 1988; 233: 201-10.
37. Nakajima M, Welch DR, Irimura T, Nicolson GL. Basement membrane degradative enzymes as possible markers of tumor metastasis. Prog Clin Biol Res 1986; 212: 113-22.
38. van Kuppevelt TH, Dennissen MABA, van Venrooij WJ, Hoet RMA, Veerkamp JH. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. J Biol Chem 1998; 273: 12960-6.
39. Yanagishita M, Hascall VC. Cell surface heparan sulfate proteoglycans. J Biol Chem 1992; 267: 9451-4.
40. Dolan M, Horchar T, Rigatti B, Hassell JR. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J Biol Chem 1997; 272: 4316-22.
41. Doege K, Chen X, Cornuet PK, Hassell J. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis. Matrix Biol 1997; 16: 211-21.